Edges in Network
| Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | GPR109B |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → GPR109B |
| (<<) BCL2A1 → GPR109B |
| (<<) CLEC2B → GPR109B |
| (<<) CSTA → GPR109B |
| (<<) CXCL1 → GPR109B |
| (<<) LCP1 → GPR109B |
| (<<) MPP1 → GPR109B |
| (<<) PIK3CD → GPR109B |
| (<<) PIM1 → GPR109B |
| (<<) PLAUR → GPR109B |
| (<<) PRKCB → GPR109B |
| (<<) PTPRE → GPR109B |
| (<<) RHOG → GPR109B |
| (<<) SERPINB1 → GPR109B |
| (<<) SLC25A37 → GPR109B |
| (<<) SOD2 → GPR109B |
| (<<) TIMM13 → GPR109B |
| (<<) TXNIP → GPR109B |
| Downstream (Children) |
|---|
| GPR109B → ADAM8 (>>) |
| GPR109B → BAD (>>) |
| GPR109B → BMPR2 (>>) |
| GPR109B → CHST2 (>>) |
| GPR109B → CREB5 (>>) |
| GPR109B → CYP1A2 (>>) |
| GPR109B → ERBB2 (>>) |
| GPR109B → ETS2 (>>) |
| GPR109B → FZD2 (>>) |
| GPR109B → G0S2 (>>) |
| GPR109B → GNRH2 (>>) |
| GPR109B → GOT2 (>>) |
| GPR109B → GYPC (>>) |
| GPR109B → HKDC1 (>>) |
| GPR109B → IL1B (>>) |
| GPR109B → IL1R2 (>>) |
| GPR109B → INE1 (>>) |
| GPR109B → KCNJ2 (>>) |
| GPR109B → MAP2K3 (>>) |
| GPR109B → MAP2K4 (>>) |
| GPR109B → MAP2K5 (>>) |
| GPR109B → MAPK7 (>>) |
| GPR109B → MMP12 (>>) |
| GPR109B → NEDD4 (>>) |
| GPR109B → NRSN2 (>>) |
| GPR109B → PI3 (>>) |
| GPR109B → PIP4K2A (>>) |
| GPR109B → PKIG (>>) |
| GPR109B → PTAFR (>>) |
| GPR109B → PTGS2 (>>) |
| GPR109B → PTMS (>>) |
| GPR109B → RAB15 (>>) |
| GPR109B → RAC3 (>>) |
| GPR109B → SMTN (>>) |
| GPR109B → SPINK1 (>>) |
| GPR109B → STK4 (>>) |
| GPR109B → TGM2 (>>) |
| GPR109B → TUBB2C (>>) |
| GPR109B → UBE2D3 (>>) |
